|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
JP2001526522A
(ja)
|
1995-02-24 |
2001-12-18 |
スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ |
前立腺特異的膜抗原およびその使用
|
|
US6962981B1
(en)
|
1996-03-25 |
2005-11-08 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6150508A
(en)
*
|
1996-03-25 |
2000-11-21 |
Northwest Biotherapeutics, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US7381407B1
(en)
|
1996-03-25 |
2008-06-03 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US6107090A
(en)
|
1996-05-06 |
2000-08-22 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
|
|
US6207805B1
(en)
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
|
GB2328871A
(en)
*
|
1997-09-05 |
1999-03-10 |
Merck & Co Inc |
Compositions for inhibiting platelet aggregation
|
|
AU3305699A
(en)
*
|
1998-02-26 |
1999-09-15 |
Beckman Coulter, Inc. |
Prostate-specific membrane antigens and methods of making and using
|
|
DK1086223T3
(da)
*
|
1998-06-01 |
2009-11-30 |
Agensys Inc |
Nye serpentintransmembranantigener udtrykt i humane cancerformer og anvendelser deraf
|
|
US20030035798A1
(en)
*
|
2000-08-16 |
2003-02-20 |
Fang Fang |
Humanized antibodies
|
|
SE9900495D0
(sv)
*
|
1999-02-12 |
1999-02-12 |
Pharmatrix Ab |
Vaccine composition
|
|
WO2000050457A1
(en)
*
|
1999-02-22 |
2000-08-31 |
Beckman Coulter, Inc. |
Prostate-specific membrane antigens and methods of making and using
|
|
EP1710256A1
(en)
*
|
1999-07-29 |
2006-10-11 |
Medarex, Inc. |
Human monoclonal antibodies to prostate specific membrane antigen
|
|
ES2277846T3
(es)
*
|
1999-07-29 |
2007-08-01 |
Medarex, Inc. |
Anticuerpos monoclonales humanos para antigeno prostatico especifico.
|
|
FR2797743B1
(fr)
*
|
1999-08-23 |
2003-08-08 |
Urogene |
Lignee cellulaire prostatique et son utilisation pour l'obtention d'une tumeur prostatique etablie chez l'animal
|
|
US6653129B1
(en)
*
|
1999-09-13 |
2003-11-25 |
The Regents Of The University Of Colorado |
Method for isolation of cells from a solution
|
|
JP4838436B2
(ja)
*
|
2001-04-04 |
2011-12-14 |
積水メディカル株式会社 |
抗ヒト肝性トリグリセリドリパーゼ抗体
|
|
IL158969A0
(en)
|
2001-06-01 |
2004-05-12 |
Cornell Res Foundation Inc |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
JP2005527474A
(ja)
|
2001-09-20 |
2005-09-15 |
コーネル リサーチ ファンデーション インコーポレーテッド |
前立腺特異的膜抗原に特異的な結合剤を用いて、皮膚障害を治療するかまたは防止するための方法および組成物
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
US20040161776A1
(en)
*
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
EP2360169B1
(en)
|
2001-10-23 |
2015-10-14 |
Psma Development Company, L.L.C. |
PSMA antibodies
|
|
EP1581794B1
(en)
|
2003-01-10 |
2008-09-17 |
Millennium Pharmaceuticals, Inc. |
Method of determining risk for prostate cancer recurrence
|
|
JP5249587B2
(ja)
|
2005-02-18 |
2013-07-31 |
メダレックス， インク． |
フコシル残基を欠く前立腺特異的膜抗原（ｐｓｍａ）に対するモノクローナル抗体
|
|
JP4324636B2
(ja)
*
|
2005-03-31 |
2009-09-02 |
アジェンシス，インコーポレイテッド |
１６１ｐ２ｆ１０ｂタンパク質に結合する抗体および関連分子
|
|
EP1726650A1
(en)
|
2005-05-27 |
2006-11-29 |
Universitätsklinikum Freiburg |
Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
|
|
AU2006294663B2
(en)
|
2005-09-26 |
2012-03-22 |
Medarex, Inc. |
Human monoclonal antibodies to CD70
|
|
ES2363891T3
(es)
|
2006-03-20 |
2011-08-18 |
The Regents Of The University Of California |
Anticuerpos contra el antígeno de células troncales de la próstata (psca) modificados genéticamente para el direccionamiento al cáncer.
|
|
US8940298B2
(en)
|
2007-09-04 |
2015-01-27 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
|
|
US8569006B2
(en)
|
2008-02-29 |
2013-10-29 |
Imec |
Cell-enzyme based biosensors
|
|
PT2326350E
(pt)
|
2008-09-08 |
2013-12-10 |
Psma Dev Company L L C |
Compostos para matar células cancerosas resistentes a taxano, que expressam psma
|
|
EP2398504B1
(en)
|
2009-02-17 |
2018-11-28 |
Cornell Research Foundation, Inc. |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
|
WO2011069019A2
(en)
|
2009-12-02 |
2011-06-09 |
David Ho |
J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
|
|
CA2833477A1
(en)
|
2011-04-21 |
2012-10-26 |
Seattle Genetics, Inc. |
Novel binder-drug conjugates (adcs) and their use
|
|
US20140161800A1
(en)
|
2011-04-22 |
2014-06-12 |
John W. Blankenship |
Prostate-Specific Membrane Antigen Binding Proteins and Related Compositions and Methods
|
|
CA2934617A1
(en)
|
2013-12-23 |
2015-07-02 |
Bayer Pharma Aktiengesellschaft |
Antibody drug conjugates (adcs) with kinesin spindle protein (ksp)
|
|
JP6971858B2
(ja)
|
2015-06-22 |
2021-11-24 |
バイエル ファーマ アクチエンゲゼルシャフト |
酵素開裂性基を有する抗体薬物複合体（ａｄｃ）および抗体プロドラッグ複合体（ａｐｄｃ）
|
|
JOP20160154B1
(ar)
*
|
2015-07-31 |
2021-08-17 |
Regeneron Pharma |
أجسام ضادة مضاد لل psma، وجزيئات رابطة لمستضد ثنائي النوعية الذي يربط psma و cd3، واستخداماتها
|
|
NZ739721A
(en)
|
2015-08-07 |
2019-09-27 |
Imaginab Inc |
Antigen binding constructs to target molecules
|
|
UA126278C2
(uk)
|
2015-09-21 |
2022-09-14 |
Аптево Рісьорч Енд Девелопмент Ллс |
Поліпептиди, які зв'язують cd3
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
JP7251981B2
(ja)
|
2016-03-24 |
2023-04-04 |
バイエル ファーマ アクチエンゲゼルシャフト |
酵素開裂基を有する細胞毒性活性剤のプロドラッグ
|
|
CN109310781B
(zh)
|
2016-06-15 |
2024-06-18 |
拜耳制药股份公司 |
具有ksp抑制剂和抗-cd123-抗体的特异性抗体-药物-缀合物(adc)
|
|
US11660351B2
(en)
|
2016-12-21 |
2023-05-30 |
Bayer Aktiengesellschaft |
Antibody drug conjugates (ADCs) having enzymatically cleavable groups
|
|
WO2018114804A1
(de)
|
2016-12-21 |
2018-06-28 |
Bayer Pharma Aktiengesellschaft |
Spezifische antikörper-wirkstoff-konjugate (adcs) mit ksp-inhibitoren
|
|
US12059472B2
(en)
|
2016-12-21 |
2024-08-13 |
Bayer Aktiengesellschaft |
Prodrugs of cytotoxic active agents having enzymatically cleavable groups
|
|
WO2019173324A1
(en)
|
2018-03-06 |
2019-09-12 |
The Trustees Of The University Of Pennsylvania |
Prostate-specific membrane antigen cars and methods of use thereof
|
|
WO2019245991A1
(en)
|
2018-06-18 |
2019-12-26 |
Eureka Therapeutics, Inc. |
Constructs targeting prostate-specific membrane antigen (psma) and uses thereof
|
|
CN112533956B
(zh)
|
2018-07-31 |
2025-05-06 |
海德堡医药研究有限责任公司 |
针对psma的人源化抗体
|